Myrtle House (Closed)

Address: MYRTLE HOUSE, 154 BLACKBURN ROAD, ACCRINGTON, LANCASHIRE, BB5 0AE

Part of Sub-ICB Location: NHS EAST LANCASHIRE

Current practice type: GP Practice

Closed: 30 Jun 2020

Practice locations are approximate, based on postcode.

Standard measures

Our 73 standard measures compare performance across England. This is the measure where Myrtle House has the greatest potential for improvement. View all 73 measures...

These are measures about low-value items which NHS England says should not routinely prescribed in primary care. This is the ranking of Myrtle House for all low-value items combined. View the 24 measures...

You can browse all of our measures by topic: Antimicrobial Stewardship (10), Cardiovascular system (11), Central Nervous system (3), Cost Saving (33), Diabetes (5), Efficacy (18), Erectile Dysfunction (1), Eye (1), Gastrointestinal system (1), Generic prescribing (2), Greener NHS (3), Infections (11), NHS England - items which should not routinely be prescribed in primary care (24), Mental Health (5), NICE (24), Nutrition (4), Opioids (5), National medicines optimisation opportunities (10), Pain (13), Mentioned in Papers (2), Reproductive system (1), Respiratory (4), Retired measures (0), Safety (25)

Savings on individual presentations

Every month, we identify the biggest cost saving opportunities for Myrtle House. We also indicate cheaper options, based on what others have prescribed.

☺ No savings this month!

Price concessions cost

We don't have current data for the impact of price concessions on Myrtle House. For historical data see the price concessions dashboard.

Ghost-branded generics

New: many practices are mistakenly prescribing generics as if they are brands. See a list of generics that may be affected here. Myrtle House .

Sign up for alerts or updates

Looking for more data?

Try our Analyse form which allows you run custom analyses on prescribing data for this practice, or view high-level prescribing trends.

OpenPrescribing Labs

Our Labs page is where we develop experimental new approaches to analysing data. All data and charts on the Labs should be treated cautiously. Our experimental Lab tools automatically identify areas that may be of interest to advanced users of OpenPrescribing, however not all charts presented may be relevant to clinical practice.
To view our first Labs prototype prescribing outlier dashboard click here